NSC |
Compound |
Enrichment |
Correlation |
NSC 121868 |
Null |
0.0018088833864761 |
0.54192267 |
NSC 165572 |
Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- |
0.0018088833864761 |
0.26769416 |
NSC 704408 |
Null |
0.0018088833864761 |
-0.25802317 |
NSC 707094 |
Null |
0.0018088833864761 |
0.34836117 |
NSC 718579 |
Null |
0.00180888338647612 |
0.36577439 |
NSC 709588 |
Null |
0.00181371860170654 |
-0.38469461 |
NSC 13479 |
Null |
0.00206000157707803 |
0.48255736 |
NSC 174121 |
Methotrexate Derivative |
0.00206000157707803 |
0.17860186 |
NSC 647638 |
1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) |
0.00206000157707803 |
-0.028497901 |
NSC 666783 |
Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol |
0.00206000157707803 |
0.15978266 |